SVF Pauling (Cayman) Ltd
SEC Form 4 insider trading activity
SVF Pauling (Cayman) Ltd has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Aug 28, 2026.
On the most recent filing, SVF Pauling (Cayman) Ltd is listed as 10% Owner at Relay Therapeutics, Inc. Inside the rolling window, SVF Pauling (Cayman) Ltd reported no open-market purchases and 1 open-market sale totaling $116.4M in RLAY.
Companies traded
Other insiders at RLAY
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$116.4M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has SVF Pauling (Cayman) Ltd made?
SVF Pauling (Cayman) Ltd has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does SVF Pauling (Cayman) Ltd trade?
SVF Pauling (Cayman) Ltd has filed SEC Form 4 disclosures for 1 company, including RLAY.
When was SVF Pauling (Cayman) Ltd's most recent SEC Form 4 filing?
SVF Pauling (Cayman) Ltd's most recent SEC Form 4 filing on Tracefour is dated Aug 28, 2026.
What is SVF Pauling (Cayman) Ltd's total buy and sell value in the current window?
Inside the rolling retention window, SVF Pauling (Cayman) Ltd bought $0 and sold $116.4M based on SEC Form 4 filings.
What was SVF Pauling (Cayman) Ltd's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 6,000,000 RLAY shares on 2026-08-25, worth $116.4M, per SEC Form 4 filings.